Antimetabolites: all 8,294 studies that test it
Page 69 of 83. Open to participants first (1,149), then studies with results posted, then the rest; newest registration first within each.
- Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC)TerminatedNCT00351195Phase 2
- Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced CholangiocarcinomaCompletedNCT00350961Phase 1/2
- Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT)CompletedNCT00350818Phase 1
- WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated VasculitidesStatus unknownNCT00349674Phase 3
- A Study of Low-Dose Decitabine in Relapsed or Refractory Acute Lymphocytic Leukemia (ALL)CompletedNCT00349596Phase 1
- TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung CancerCompletedNCT00349219Phase 3
- Trial on Refinement of Early Stage Lung Cancer Adjuvant TherapyCompletedNCT00349089Phase 2
- Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal CancerCompletedNCT00349076Phase 3
- Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin CCompletedNCT00346489Phase 4
- Antenatal Allopurinol in Intrauterine Growth RestrictionStatus unknownNCT00346463Not applicable
- Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid CancerCompletedNCT00346359Phase 2
- 1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR.CompletedNCT00345696Phase 2
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic MalignanciesCompletedNCT00343798Phase 1
- Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior TherapyCompletedNCT00343720Phase 2
- S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric CancerStatus unknownNCT00343668Phase 2
- Docetaxel in Locally Advanced Gastric AdenocarcinomaCompletedNCT00343239Phase 2
- Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell LymphomaCompletedNCT00338494Phase 1
- Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic MelanomaActive, not recruitingNCT00338377Phase 2
- Gemcitabine for Marginal Zone LymphomaTerminatedNCT00337259Phase 2
- Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic LeukemiaCompletedNCT00337246Phase 2
- Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By SurgeryCompletedNCT00336960Phase 2
- Preop Chemoradiation Resectable PancreasCompletedNCT00336648Phase 2
- Evaluating the Safety of G-CSF Mobilization in Individuals With Beta Thalassemia MajorCompletedNCT00336362Not applicable
- Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell LymphomaActive, not recruitingNCT00336063Phase 1
- Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By SurgeryCompletedNCT00335543Phase 2
- Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis TreatmentStatus unknownNCT00332306Phase 3
- A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis CStatus unknownNCT00332176Phase 2
- CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung CancerCompletedNCT00330746Phase 2
- Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung CancerCompletedNCT00330044Phase 1
- Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung CancerWithdrawnNCT00329472Phase 3
- Study of Satraplatin With Capecitabine to Treat Advanced Solid MalignanciesTerminatedNCT00329329Phase 1
- A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV)CompletedNCT00328549Phase 2
- Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast CancerCompletedNCT00327743Phase 1/2
- Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic AdenocarcinomaCompletedNCT00327327Phase 1
- Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic MelanomaCompletedNCT00324623Phase 1
- Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days RegimenStatus unknownNCT00324610Phase 1/2
- AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaStatus unknownNCT00324597Phase 1
- Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric AdenocarcinomaCompletedNCT00323830Phase 3
- Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.CompletedNCT00323804Phase 2/3
- Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney CancerTerminatedNCT00323791Phase 2
- Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic CancerStatus unknownNCT00323583Phase 2
- FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal CancerTerminatedNCT00323011Phase 2
- Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung CancerTerminatedNCT00321308Phase 2
- Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV MelanomaCompletedNCT00317759Phase 1
- Gemcitabine and Capecitabine in Patients With Advanced Pancreatic CancerCompletedNCT00316420Phase 1
- Development of a New Method for Steady-State Measurement of NO Lung Diffusing Capacity in Healthy SubjectsStatus unknownNCT00315965Phase 1
- Topotecan in Combination With Pemetrexed in Patients With Advanced MalignanciesCompletedNCT00315861Phase 1
- NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus CoinfectionCompletedNCT00315432Phase 2
- Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple MyelomaCompletedNCT00313625Phase 2
- Dendritic Cell Vaccination During Lymphoid ReconstructionCompletedNCT00313508Phase 1
- Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer TherapyCompletedNCT00312988Phase 3
- Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai ChildrenCompletedNCT00312091Phase 1/2
- Sequential Versus Combination Chemotherapy in Advanced Colorectal CarcinomaCompletedNCT00312000Phase 3
- Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell CarcinomaTerminatedNCT00311467Phase 3
- Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHLCompletedNCT00311129Phase 2
- Chronic Hepatitis C Non-Responder Study With AdoMet and BetaineCompletedNCT00310336Phase 2/3
- Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's LymphomaWithdrawnNCT00310128Phase 2
- Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the UrotheliumCompletedNCT00310011Phase 2
- Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative PatientsCompletedNCT00309569Phase 3
- Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast CancerCompletedNCT00309556Phase 3
- Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes CCompletedNCT00309530Phase 3
- Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive PatientsCompletedNCT00309478Phase 3
- 14 vs 24 Weeks HCV Treatment to Genotype 2/3 Patients With Rapid Virological ResponseCompletedNCT00308048Phase 3
- Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic CancerTerminatedNCT00307723Phase 1/2
- Treatment of Necrotizing Vasculitides for Patients Older Than 65 YearsCompletedNCT00307671Phase 4
- IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic VasculitisTerminatedNCT00307645Phase 3
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid TumorsCompletedNCT00307255Phase 1
- Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00305786Phase 2
- Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal CancerCompletedNCT00305734Phase 2
- Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First RemissionCompletedNCT00305708Phase 1/2
- A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)CompletedNCT00304551Phase 3
- Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By SurgeryCompletedNCT00304135Phase 2/3
- Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic CancerCompletedNCT00304018Phase 1
- Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase GeneCompletedNCT00303927Phase 2
- Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00303758Phase 3
- Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryStatus unknownNCT00303745Phase 2
- PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CMLCompletedNCT00303290Phase 1
- Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic CancerCompletedNCT00301951Phase 1
- Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By SurgeryStatus unknownNCT00301925Phase 3
- Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic CancerWithdrawnNCT00301912Phase 2
- Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas CancerCompletedNCT00300950Phase 2
- Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve SubjectsCompletedNCT00299936Phase 3
- Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination TherapyStatus unknownNCT00299923Phase 3
- Methotrexate in the Treatment of Axial SpondyloarthritisWithdrawnNCT00298012Phase 4
- Preoperative Combined Radiochemotherapy for Patients With Rectal CarcinomaCompletedNCT00297141Phase 2
- Preoperative Chemoradiation With Capecitabine and CetuximabCompletedNCT00297128Phase 2
- Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Rectal CancerCompletedNCT00296608Phase 3
- Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal CancerTerminatedNCT00296062Phase 1
- Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancerCompletedNCT00296023Not applicable
- Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency DiseaseCompletedNCT00295971Phase 1
- Cytarabine and Clofarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaCompletedNCT00295841Phase 1
- Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by GemcitabineCompletedNCT00294385Phase 3
- The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal CancerCompletedNCT00294359Phase 2/3
- Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System LymphomaStatus unknownNCT00293475Phase 1/2
- Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative DisordersCompletedNCT00293410Phase 1
- 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00293345Phase 1
- Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early ArthritisStatus unknownNCT00291915Phase 4
- Phase I/II CT 2106 and 5-FU/FA in Colorectal CancerCompletedNCT00291785Phase 1/2
- Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck CancerCompletedNCT00291707Phase 1
- Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic CancerCompletedNCT00290641Not applicable